ATE348334T1 - Integriertes assay für organfunktion, drogen und/oder metaboliten - Google Patents
Integriertes assay für organfunktion, drogen und/oder metabolitenInfo
- Publication number
- ATE348334T1 ATE348334T1 AT00917690T AT00917690T ATE348334T1 AT E348334 T1 ATE348334 T1 AT E348334T1 AT 00917690 T AT00917690 T AT 00917690T AT 00917690 T AT00917690 T AT 00917690T AT E348334 T1 ATE348334 T1 AT E348334T1
- Authority
- AT
- Austria
- Prior art keywords
- metabolites
- drugs
- organ function
- integrated assay
- organ
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 3
- 210000000056 organ Anatomy 0.000 title abstract 3
- 239000002207 metabolite Substances 0.000 title abstract 2
- 238000003556 assay Methods 0.000 title 1
- 239000003550 marker Substances 0.000 abstract 2
- 230000003993 interaction Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/52—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26424999A | 1999-03-08 | 1999-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE348334T1 true ATE348334T1 (de) | 2007-01-15 |
Family
ID=23005201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00917690T ATE348334T1 (de) | 1999-03-08 | 2000-03-01 | Integriertes assay für organfunktion, drogen und/oder metaboliten |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6627153B1 (de) |
| EP (1) | EP1159612B1 (de) |
| AT (1) | ATE348334T1 (de) |
| AU (1) | AU3862400A (de) |
| DE (1) | DE60032339T2 (de) |
| DK (1) | DK1159612T3 (de) |
| HK (1) | HK1042942B (de) |
| WO (1) | WO2000054051A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7585680B2 (en) * | 2003-08-28 | 2009-09-08 | Marshfield Medical Research And Education Foundation | Method and device for monitoring medication usage |
| US20080274552A1 (en) * | 2007-05-04 | 2008-11-06 | Brian Guthrie | Dynamic Information Transfer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6279362A (ja) * | 1985-10-02 | 1987-04-11 | Fuji Photo Film Co Ltd | 酵素活性測定に用いる分析要素 |
| US4752568A (en) * | 1986-01-13 | 1988-06-21 | Eastman Kodak Company | Labeled hydantoin conjugate and its use in analytical element and immunoassays |
| CA2010165A1 (en) * | 1989-03-13 | 1990-09-13 | Richard L. Hurtle | Compact semi-programmable device for reading reagent test strips and method relating thereto |
| US5232668A (en) * | 1991-02-27 | 1993-08-03 | Boehringer Mannheim Corporation | Test strip holding and reading mechanism for a meter |
| US5695949A (en) * | 1995-04-07 | 1997-12-09 | Lxn Corp. | Combined assay for current glucose level and intermediate or long-term glycemic control |
| US6306347B1 (en) * | 1998-01-21 | 2001-10-23 | Bayer Corporation | Optical sensor and method of operation |
-
2000
- 2000-03-01 DK DK00917690T patent/DK1159612T3/da active
- 2000-03-01 DE DE60032339T patent/DE60032339T2/de not_active Expired - Lifetime
- 2000-03-01 WO PCT/US2000/005369 patent/WO2000054051A1/en not_active Ceased
- 2000-03-01 US US09/914,655 patent/US6627153B1/en not_active Expired - Lifetime
- 2000-03-01 AU AU38624/00A patent/AU3862400A/en not_active Abandoned
- 2000-03-01 AT AT00917690T patent/ATE348334T1/de not_active IP Right Cessation
- 2000-03-01 HK HK02104285.4A patent/HK1042942B/en not_active IP Right Cessation
- 2000-03-01 EP EP00917690A patent/EP1159612B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1159612A1 (de) | 2001-12-05 |
| DK1159612T3 (da) | 2007-01-22 |
| AU3862400A (en) | 2000-09-28 |
| US6627153B1 (en) | 2003-09-30 |
| WO2000054051A1 (en) | 2000-09-14 |
| EP1159612B1 (de) | 2006-12-13 |
| DE60032339D1 (de) | 2007-01-25 |
| DE60032339T2 (de) | 2007-04-12 |
| HK1042942B (en) | 2007-09-14 |
| HK1042942A1 (en) | 2002-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE412387T1 (de) | Medizinische vorrichtungen | |
| CY1114420T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη για την αγωγη της ψωριασης | |
| DE60122723D1 (de) | Vorrichting zur transdermalen abnahme und verabreichung von einer substanz beim patient | |
| DE60130373D1 (de) | Messstreifenspenderanordnung | |
| HRP20070374T3 (en) | Formulations comprising ecteinascidin and a disaccharide | |
| ATE337817T1 (de) | Medizinisches gerät | |
| ATE548074T1 (de) | Programmierapparat mit interner antenne und display für eine medizinische vorrichtung | |
| CL2008002866A1 (es) | Uso de (s,s)-reboxetina en la preparacion de un medicamento util en el tratamiento de un trastorno adictivo, trastorno mental, trastorno de deficit atencional, trastorno bipolar, obesidad, trastorno de panico, trastorno psicotico, sindrome de inhibicion selectiva de la recaptacion de serotonina, entre otras (sol. div. 1765-00). | |
| ATE535212T1 (de) | Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit | |
| ATE550071T1 (de) | Programmierer für ein medizinprodukt mit selektiver inaktivierung der anzeige bei telemetrie | |
| SV2006002100A (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos ref. p-sv-78.159/msu | |
| ATE218142T1 (de) | Nitratester von corticoid verbindungen und die therapeutische verwendungen davon | |
| ATE237321T1 (de) | 20-hete antagonisten und agonisten | |
| ATE417560T1 (de) | Chirurgischer nagel | |
| DE60032339D1 (de) | Integriertes assay für organfunktion, drogen und/oder metaboliten | |
| TR200503846T2 (tr) | Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı | |
| CY1107062T1 (el) | ΧΡΗΣΗ ΔΡΑΣΤΙΚΩΝ ΟΥΣΙΩΝ ΜΕ ΔΡΑΣΗ ΑΓΩΝΙΣΤΗ μ-ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΚΑΙ ΔΡΑΣΗ ΑΝΤΑΓΩΝΙΣΤΗ ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ ΣΥΝΔΥΑΣΜΟΥ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΚΑΡΚΙΝΟΥ | |
| DE69731649D1 (de) | Konjugate und spezifische immuntests des methadonmetaboliten 2-ethylidin-1,5-dimethyl-3,3-diphenyl-3,3-diphenylpyrrolidin | |
| HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
| DE59708325D1 (de) | Selbstklebender indikator | |
| NO20050216L (no) | Steroidkonjugater samt fremstilling og anvendelse derav | |
| EP1797898A4 (de) | Arzneimittel zur prävention/behandlung von arteriosklerose | |
| ATE487139T1 (de) | Diagnostikum und therapeutikum gegen bauchspeicheldrüsenkrebs | |
| ATE424196T1 (de) | Pharmazeutische zusammensetzungen mit platin- komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen | |
| AR033862A1 (es) | Formulacion de medicamento que contiene un agente agonista muscarinico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |